Stock KLBF PT KALBE FARMA TBK.
Add to a list
To use this feature you must be a member
Log inSign up

Company PT Kalbe Farma Tbk.

Equities

KLBF

ID1000125107

Pharmaceuticals

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
1,405 IDR +0.36% Intraday chart for PT Kalbe Farma Tbk. -5.07% -12.73%
Apr. 01 PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 20 Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy MT

Business Summary

PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.

Number of employees: 13,108

Sales per Business

IDR in Million2022Weight2023Weight Delta
Distribution and Logistic
36.6 %
10,801,381 37.3 % 11,141,107 36.6 % +3.15%
Nutritionals
26.2 %
7,830,659 27.1 % 7,985,307 26.2 % +1.97%
Prescription Pharmaceutical
25.0 %
6,148,609 21.3 % 7,624,594 25.0 % +24.01%
Consumer Health
12.1 %
4,152,854 14.4 % 3,698,125 12.1 % -10.95%

Sales per region

IDR in Million2022Weight2023Weight Delta
Indonesia
93.8 %
27,242,789 94.2 % 28,559,990 93.8 % +4.84%
International
6.2 %
1,690,713 5.8 % 1,889,144 6.2 % +11.74%

Managers

Managers TitleAgeSince
Vidjongtius CEO
 Chief Executive Officer 59 96-12-31
Kartika Setiabudy DFI
 Director of Finance/CFO - 17-01-31
Bernadette Ruth Setiady CHM
 Chairman 61 97-02-28
Danny Natalies CTO
 Chief Tech/Sci/R&D Officer - -
Santoso Oen BRD
 Director/Board Member 59 99-12-31
Lukito Kurniawan Gozali IRC
 Investor Relations Contact 45 18-09-30
Bernadus Karmin Winata IRO
 Public Communications Contact 59 97-06-10
Adhiguna A. Herwindha LAW
 General Counsel 41 05-12-31
Jessyca Sentosa HRO
 Human Resources Officer - -
Mulialie PRN
 Corporate Officer/Principal 54 21-05-26

Members of the board

Members of the board TitleAgeSince
Santoso Oen BRD
 Director/Board Member 59 99-12-31
Ferdinand Aryanto BRD
 Director/Board Member 51 07-12-31
Bernadette Ruth Setiady CHM
 Chairman 61 97-02-28
Ronny Hadiana BRD
 Director/Board Member 52 14-12-31
Adi Harsono BRD
 Director/Board Member 69 20-05-17
Rhenald Kasali BRD
 Director/Board Member 63 22-05-18
Lilis Halim BRD
 Director/Board Member 63 19-05-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 46,875,122,110 18,960,573,673 ( 40.45 %) 619,480,700 ( 1.322 %) 40.45 %

Shareholders

NameEquities%Valuation
Theresia Harshini
10.46 %
4,903,185,740 10.46 % 456 M Rp
Khouw Lip Swan
10.29 %
4,824,509,485 10.29 % 449 M Rp
Boenjamin Setiawan
10.07 %
4,718,121,940 10.07 % 439 M Rp
Gerda Veronica
9.504 %
4,454,807,040 9.504 % 414 M Rp
Maria Karmila
9.472 %
4,439,895,440 9.472 % 413 M Rp
Franciscus Bing Aryanto
8.195 %
3,841,639,040 8.195 % 357 M Rp
PT KALBE FARMA TBK.
1.322 %
619,480,700 1.322 % 58 M Rp
PT Schroder Investment Management Indonesia
0.7153 %
335,280,800 0.7153 % 31 M Rp
MFS International Singapore Pte. Ltd.
0.4794 %
224,705,600 0.4794 % 21 M Rp
BLI - Banque de Luxembourg Investments SA
0.2773 %
130,000,000 0.2773 % 12 M Rp
NameEquities%Valuation
PNC Investments LLC
0.000001 %
3 0.000001 % 56 Rp

Holdings

NameEquities%Valuation
PT ENSEVAL PUTERA MEGATRADING TBK.
92.47%
 2,504,801,795 92.47% 383,885,923 $
PT KALBE FARMA TBK.
1.32%
 619,480,700 1.32% 57,630,290 $

Company contact information

PT Kalbe Farma Tbk

Gedung KALBE Jalan Let. Jend. Suprapto Kavling 4

10510, Jakarta

+62 21 4287 3888

http://www.kalbe.co.id
address PT Kalbe Farma Tbk.(KLBF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for PT Kalbe Farma Tbk.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,405 IDR
Average target price
1,773 IDR
Spread / Average Target
+26.22%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PT KALBE FARMA TBK. Stock PT Kalbe Farma Tbk.
-12.73% 4B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.46% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.38% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.86% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.44% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.34% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.13% 215B
NOVARTIS AG Stock Novartis AG
+2.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-7.65% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.79% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KLBF Stock
  4. Company PT Kalbe Farma Tbk.